Huison Biotech Develops Active Substances from Marine Microbial Strains

“Huison Biotech” secured tens of millions of Chinese yuan (several million dollars) in financing, which will be used to expand the production capacity of tobacco enzyme preparations and develop the market for probiotics products. It is reported that Huison Biotech has established a strategic cooperation with the Third Institute of Oceanography of the Ministry of Natural Resources, establishing the Marine Biological Products Joint R&D Center to develop various strains and multiple patents. At present, Huison Biotech possesses microbial resources, including lactobacillus plantarum derived from deep-sea whales and marine strains that can directly generate fucoidan. (Source: FoodTalks)

Sign Up to Receive China Updates Weekly Newsletter for FREE, HERE

Visit HPA-China’s Information Hub, HERE